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PAssessing Vascular Function
Conduit Artery Constriction Mediated by Low Flow
A Novel Noninvasive Method for the Assessment of Vascular Function
Tommaso Gori, MD, PHD,*† Saverio Dragoni, MD,* Monica Lisi, MD,* Giuseppe Di Stolfo, MD,*
Serena Sonnati, MD,* Massimo Fineschi, MD,* John D. Parker, MD†
Siena, Italy; and Toronto, Ontario, Canada
Objectives We describe and validate a novel noninvasive method that complements the data from “traditional” flow-
mediated dilation (FMD) studies.
Background The study of peripheral vascular reactivity provides important diagnostic and prognostic information in patients
with (or at risk for) cardiovascular disease.
Methods High-resolution ultrasound and automatic computerized analysis were used to measure the diameter of the radial
artery at rest and in conditions of locally decreased and increased shear stress (respectively, low–flow-mediated con-
striction [L-FMC] and flow-mediated dilation [FMD]). A composite end point (L-FMC FMD) was also calculated. A
total of 196 studies were performed.
Results When the repeatability of the method was tested, the range of variation across measurements was 1.1% for
L-FMC and 1.7% for FMD; the intraclass correlation coefficient was 0.80 and 0.68, respectively. Low–flow-
mediated constriction, FMD, and their composite end point were significantly blunted after acute smoking, in
coronary artery disease patients, and in hypertensive patients as compared with that seen in healthy age-
matched volunteers (p  0.01, analysis of variance). Low–flow-mediated constriction, but not FMD, was blunted
(p  0.05) after administration of fluconazole (an inhibitor of a cytochrome P450-derived endothelium-derived
hyperpolarization factor) and aspirin (an inhibitor of cyclooxygenase). Flow-mediated dilation, but not L-FMC, was
blunted (p  0.05) by nitric oxide synthase inhibition.
Conclusions Low–flow-mediated constriction is a simple, rapid, and accurate measure of resting arterial tone that does not
require further procedures as compared with “traditional” FMD measurements. While FMD measures endothelial
responses to sudden increases in shear stress, L-FMC is a measure of the response to resting shear stress lev-
els, and, therefore, it provides additional information that is complementary to FMD. (J Am Coll Cardiol 2008;
51:1953–8) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.01.049a
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Plow-mediated dilation (FMD) (1) is a simple and noninvasive
easure of the capacity of the endothelium, when stimulated
y a sudden increase in shear stress, to cause smooth muscle
ell relaxation and vasodilation. Importantly, while FMD
easures the “recruitability” of endothelial vasomotor function
i.e., the capacity of the endothelium to modify its biosynthesis
nd release of mediators to produce vasodilation), it does not
rovide information regarding the vascular response to resting
evels of shear stress. This study reports a series of studies
imed at developing and validating a new method (which, in
rom the *Department of Internal, Cardiovascular and Geriatric Medicine, University
f Siena, Siena, Italy; and the †Division of Cardiology, Department of Medicine,
ount Sinai and University Health Network Hospitals, University of Toronto,
oronto, Ontario, Canada. Dr. Gori is the recipient of a grant from the Italian
inistry of Research. Dr. Parker holds a Career Investigator Award from the Heart
nd Stroke Foundation of Ontario, Canada. This study was funded by a grant from
he Heart and Stroke Foundation of Canada.r
Manuscript received October 24, 2007; revised manuscript received December 21,
007, accepted January 6, 2008.nalogy with FMD, we termed “low–flow-mediated constric-
ion” or L-FMC) that allows quantification of this response.
his measurement can be made at the same time as traditional
MD, and it provides information that is both complementary
nd additive to that of FMD, therefore improving its diagnos-
ic capacities and, potentially, clinical utility.
ethods
his study was approved by the local ethics committee; written
nformed consent was obtained in all cases. All studies were
onducted between 11 AM and 2 PM. Subjects were in a fasting
tate for at least 6 h. Vascular function was measured in female
ubjects at the end of the menstrual cycle.
See page 1965
opulation. A total of 196 studies were performed. For
eproducibility (variability between observers) analysis, 50 stud-
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Assessment of Vascular Function May 20, 2008:1953–8ies were analyzed twice by 2 ob-
servers. For repeatability (variabil-
ity between occasions), 25 healthy
young volunteers (age range 25 to
34 years, 7 women) underwent
measurement of L-FMC and
FMD on 2 occasions separated by
24 h. For the comparison of
L-FMC measurements between
healthy subjects and patients with
risk factors and/or cardiovascular
disease, 20 healthy young volun-
teers, 15 healthy middle-age
adults, 15 smokers, 18 hyperten-
ive patients, and 13 patients with known coronary artery
isease (CAD) were studied. For mechanistic studies, healthy
oung volunteers (age 24 to 37 years) were enrolled. All
ubjects had normal (180 mg/dl) cholesterol and triglyceride
150 mg/dl) levels and no family history of premature
ardiovascular disease. Healthy young and middle-age volun-
eers were lifelong nonsmokers with systolic blood pressure
130 mm Hg and diastolic blood pressure 80 mm Hg.
mokers had a history of 5 to 10 cigarettes/day for 3 to 10 years
nd smoked 1 cigarette immediately before L-FMC measure-
ent. Hypertensive patients had undergone 24-h blood pres-
ure monitoring that documented average systolic values140
nd diastolic values90 mm Hg. No subject was on treatment
ith any drug (including supplemental vitamins), none had
istory of diabetes, and none had clinical evidence of CAD or
eripheral artery disease. The 13 patients with CAD had at
Figure 1 Representative Plot of FMD and Low-FMC
Radial artery diameter changes throughout the study of low–flow-mediated constriction
surement, the wrist cuff is inflated (arrowhead) to suprasystolic pressure. At this poin
plateau (low-FMC) at approximately 3’ 30” after wrist cuff inflation and does not furthe
increased shear stress causes radial artery dilation (FMD). Therefore, L-FMC is a nega
point. Image from the analysis software (4).
Abbreviations
and Acronyms
CAD  coronary artery
disease
EDHF  endothelium-
derived hyperpolarization
factor
FMD  flow-mediated
dilation
L-FMC  low–flow-mediated
constriction
NO  nitric oxideeast 1 stenosis70% at angiography and were clinically stable
or the previous month. Seven of them had hypertension, 7 had
ypercholesterolemia, and 5 had diabetes mellitus. None of
hem had systolic or diastolic heart failure. All CAD patients
ere taking aspirin.
easurement of arterial diameter, L-FMC, and FMD.
he radial artery was imaged using high-resolution ultrasound,
nd its diameter was measured using automatic custom-
esigned software (2–4). Low–flow-mediated constriction was
alculated as the percent decrease in arterial diameter in the last
0 s of cuff occlusion as compared with resting diameter.
low-mediated dilation was calculated as the maximum per-
ent increase in arterial diameter after cuff deflation as com-
ared with resting diameter. Finally, a composite end point was
alculated as the sum of the absolute values of FMD and
-FMC (Fig. 1). Radial artery blood flows were measured at
est, 15 s before wrist cuff deflation, and immediately upon cuff
eflation using pulsed-wave Doppler. All data were analyzed in
randomized, blinded fashion.
echanistic studies. THE ROLE OF NITRIC OXIDE (NO). Low–
ow-mediated constriction and FMD were measured dur-
ng intra-arterial infusion of the NO synthase inhibitor
evo-N-monomethyl arginine (8 mol/min) or normal sa-
ine in 9 healthy male subjects (5). Infusions were started 10
in before L-FMC and FMD measurements.
HE EFFECT OF FLUCONAZOLE AND ASPIRIN. Fourteen
ealthy volunteers (4 women) were enrolled for this double-
lind, placebo-controlled, cross-over trial. In 3 separate visits,
ubjects were randomized to receive placebo, fluconazole (150
and flow-mediated dilation (FMD). After 1 min of resting radial artery diameter mea-
radial artery diameter progressively decreases in healthy volunteers until it reaches a
trict for longer occlusion times. Upon wrist cuff deflation (double arrowhead), the
mber, while FMD is a positive one. Doppler blood flows are reported at each time(FMC)
t, the
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May 20, 2008:1953–8 Assessment of Vascular Functiong orally, an inhibitor of the isoform 2C9 of the cytochrome
450, which is believed to be involved in the synthesis of an
ndothelium-derived relaxing factor [EDHF]) (6,7) or aspirin
an inhibitor of cyclooxygenase products such as prostaglan-
ins, 500 mg orally). This dosage of fluconazole is expected to
chieve plasma concentrations in the range of 3 g/ml (8),
hich has been previously shown to inhibit EDHF production
7). Two hours later, L-FMC and FMD were measured as
reviously described.
Figure 2 Repeatability of FMD and L-FMC
Correlation analysis across consecutive (24 h) measurements of L-FMC (A) and FMD
(B). The intraclass correlation coefficient (ICC) was higher for L-FMC. Abbreviations as
in Figure 1.
Figure 3 Bland-Altman Plots for Consecutive
Measurements of L-FMC and FMD
The plots show a higher concordance for L-FMC (left) measurements.
The dotted lines represent  1.96 SD. Abbreviations as in Figure 1. mHE ROLE OF BLOOD PRESSURE CHANGES AND DISTEND-
NG PRESSURE. A 21-gauge intra-arterial cannula was
laced in the left brachial artery of 11 male subjects (5).
nvasive systolic, mean, and diastolic blood pressures were
easured at rest and during inflation of a pneumatic cuff
laced around the homolateral wrist. Another group of 15
ubjects underwent the same measurements with the pneu-
atic cuff placed around the contralateral wrist.
HE ROLE OF SYSTEMIC REFLEXES. A wrist cuff was placed
round the right wrist, and arterial diameter was measured
ontralaterally in 5 subjects (2 women).
tatistical analysis. Data are presented as mean SD. For
eproducibility and repeatability analysis, the appropriate
ntraclass correlation coefficient and range of variation
mean of the absolute differences between consecutive mea-
urements) was calculated. Bland-Altman plots (9) were
onstructed for both L-FMC and FMD, and the coefficient
f repeatability was calculated (1.96 times the standard
eviation of the difference between consecutive measure-
ents). Both 1- and 2-way analysis of variance (ANOVA)
ere employed for analysis of differences within and be-
ween patient and control groups. For mechanistic studies,
tests or repeated measures ANOVA were employed
Statview version 5, SAS Institute Inc., Cary, North Caro-
ina). Post-hoc comparisons were done with the Fisher test.
he threshold for significance was p  0.05.
esults
n 2 subjects, scans were of insufficient quality to assess FMD.
ow–flow-mediated constriction was assessed in all subjects.
eproducibility of L-FMC and FMD. The mean range
f variation between 2 sets of arterial diameter measure-
ents using the software employed here is 0.03 mm. The
ean range of interobserver variation for the measurement
f percent L-FMC and FMD was, respectively, 0.45%
0.02% to 2.9%) and 0.60% (0.04% to 2.9%) (n 50 studies
n arteries with a mean diameter of approximately 2.5 mm,
 2 observers). The corresponding intraclass coefficient
as 0.98 for both L-FMC and FMD.
epeatability of L-FMC and FMD. The intraclass cor-
elation coefficient for repeated measurements of baseline
iameter was 0.85; for L-FMC it was 0.80; for FMD it was
he Role of NOS
Table 1 The Role of NOS
Normal Saline L-NMMA p Value
Resting diameter, mm 2.67 0.1 2.63 0.1 NS
 during cuff inflation 0.15 0.0 0.15 0.0 NS
 after cuff deflation 0.20 0.0 0.11 0.0 0.05
Resting blood flow, ml/min 21 10 16 7 0.05
Blood flow during cuff inflation 6 4 6 2 NS
Blood flow after cuff deflation 133 58 125 56 NS
adial artery diameters at rest and change during cuff inflation and after cuff deflation. Levo-N-
onomethyl arginine (L-NMMA) blunted flow-mediated dilation but did not modify low–flow-
ediated constriction.
NOS  nitric oxide synthase.
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Assessment of Vascular Function May 20, 2008:1953–8.68 (Fig. 2). The range of variation for each of these
ariables was, respectively, 0.15% (0.0% to 0.32%), 1.1%
0.0% to 2.7%), and 1.7% (0.1% to 5.2%). Bland and
ltman plots for repeated L-FMC and FMD measure-
ents are presented in Figure 3. The coefficient of repeat-
bility was 1.5% for L-FMC and 3.2% for FMD.
echanistic studies. THE ROLE OF NO. While blunting
lood flow, levo-N-monomethyl arginine (L-NMMA) did
ot modify resting radial artery diameter or L-FMC. As
ompared with vehicle, both arterial diameter during reac-
ive hyperemia and FMD were significantly blunted during
-NMMA (Table 1, Fig. 4).
HE ROLE OF EDHF AND CYCLOOXYGENASE PRODUCTS. Nei-
her fluconazole nor aspirin modified resting radial artery
iameter, resting blood flow, FMD, or blood flow during
nflation and deflation of the cuff. In contrast, L-FMC was
ignificantly attenuated after both agents (Table 2, Fig. 4).
Figure 4 Mechanistic Hypothesis
(Left) Low–flow-mediated constriction (FMC) and FMD measurements during infusi
was not modified by L-NMMA, suggesting that nitric oxide plays a lesser role in reg
after placebo, fluconazole (150 mg orally), and aspirin (500 mg orally). Low–FMC w
Figure 1.
The Role of EDHF and COX-Derived Products
Table 2 The Role of EDHF and COX-Derived
Placebo
Resting diameter, mm 2.31 0.34
 during cuff inflation 0.14 0.04
 after cuff deflation 0.12 0.07
Resting blood flow, ml/min 20 9
During cuff inflation 2 2
After cuff deflation 144 43
Radial artery diameters at rest and the change in diameter during c
low–flow-mediated constriction but did not modify flow-mediated dil
change from baseline.
COX  cyclooxygenase; EDHF  endothelium-derived hyperpolarization facHEROLEOFBLOODPRESSURECHANGES. Inflation of a wrist
uff placed around the homolateral wrist caused a nonsig-
ificant (p  0.1) increase in systolic blood pressure mea-
ured invasively at the level of the left brachial artery while
ot changing mean and diastolic blood pressure or heart rate
Table 3). Inflation of a pneumatic cuff placed on the right
rist did not affect these parameters nor did it modify the
rterial diameter of the left radial artery (resting diameter
.37  0.2 mm; during cuff occlusion 2.38  0.2 mm,
 NS).
-FMC in health and disease. In healthy volunteers,
-FMC varied from 0.1% to 12.2%; FMD varied from
.4% to 14.8%. Flow-mediated dilation and L-FMC were
imilar in healthy young and middle-age volunteers and
ere significantly blunted after acute smoking in hyperten-
ive and CAD patients (p  0.01 for all). The composite
nd point was also significantly blunted after smoking in
ormal saline or levo-N-monomethyl arginine (L-NMMA) (8 mol/min). Low–FMC
g resting arterial tone. *p  0.01. (Right) Low-FMC and FMD measurements
nificantly blunted after fluconazole and aspirin. *p  0.05. Abbreviations as in
ucts
Aspirin Fluconazole p Value
2.30 0.31 2.30 0.34 NS
0.10 0.08 0.08 0.07 0.05*
0.14 0.08 0.14 0.1 NS
20 19 18 10 NS
2 3 2 3 NS
130 40 128 58 NS
ation and after cuff deflation. Both aspirin and fluconazole blunted
p  0.05 for low–flow-mediated constriction expressed as percenton of n
ulatin
as sigProd

uff infl
ation. *tor.
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May 20, 2008:1953–8 Assessment of Vascular Functionypertensive and CAD patients (Table 4, Fig. 5, right).
esting blood flow, blood flow during cuff inflation, and
eactive hyperemia were similar across groups. A weak
ut significant positive correlation was found between
-FMC and percent decrease in blood flow during cuff
cclusion (R2  0.13, p  0.01). There was no correla-
ion between L-FMC and FMD in the whole study
opulation (R2  0.03, p  0.1) or in any of the subgroups.
iscussion
mong the methods that allow measurement of endothelial
unction in humans in vivo, FMD has rapidly gained
opularity because of its simplicity, reproducibility, and
oninvasiveness. One important limitation of FMD is that
lthough this technique measures how much the endothe-
ium modifies its biosynthetic activity in response to sudden
ncreases in shear stress (i.e., endothelial “recruitability”), it
oes not provide information concerning the effect of shear
tress in resting conditions (i.e., “shear stress-dependent
asal tone” or “resting endothelial tone”). To address this,
e developed and validated a novel measure that is also
oninvasive, reproducible, and does not require further
rocedures as compared with “traditional” FMD.
The important additional information brought by intro-
uction of L-FMC is that this variable provides information
oncerning the control of arterial tone at rest, therefore
ack of a Role of Distending Pressure in L-FMC
Table 3 Lack of a Role of Distending Pressure in L-FMC
Homolateral Cuff Contralateral Cuff
Systolic blood pressure, mm Hg
At rest 121 3 114 3
During cuff inflation 125 3 113 5
Diastolic blood pressure
At rest 67 2 65 2
During cuff inflation 67 3 62 4
Mean blood pressure
At rest 85 2 81 2
During cuff inflation 86 2 79 4
omolateral and contralateral wrist cuff inflation did not modify blood pressure.
L-FMC  low–flow-mediated constriction.
MD and L-FMC in Health and Disease
Table 4 FMD and L-FMC in Health and Disease
Healthy Young Healthy Age-Matche
Age, yrs (range) 29 3 (25–30)* 53 3 (37–65)*
Resting diameter, mm 2.25 0.3 2.41 0.4†
 during cuff inflation, mm 0.12 0.05 0.12 0.08
 after cuff deflation, mm 0.17 0.08 0.16 0.11
Blood flow, ml/min
At rest 16 18 14 8
During cuff inflation 3 2 2 1
Reactive hyperemia 121 68 101 67
Resting heart rate, beats/min 66 12 67 10
here was no difference across groups in heart rate and blood flow at any time point. Difference
nd the hypertensive groups) and were not significant (p 0.67). The median was not different a
p  0.05 for the comparison with corresponding control subjects.
FMD  flow-mediated dilation; L-FMC  low–flow-mediated constriction.omplementing (and not overlapping with) the information
rovided by FMD. This point is further emphasized by the
ack of a correlation between L-FMC and FMD; the
bsence of such correlation highlights the incremental value
f L-FMC and is a stimulus for further studies investigating
he relationship between “basal” and “recruitable” responses
o shear stress. Furthermore, introduction of the measure-
ent of L-FMC allows calculating a composite end point,
xpressed as the sum of the absolute values of FMD and
-FMC. This end point provides a comprehensive mea-
urement of shear stress-dependent vasomotion, which
ombines both resting tone and endothelial “recruitability.”
While mechanisms underlying FMD have been described
n detail, less is understood concerning the mediators
nvolved in modulating resting conduit artery tone. Our data
how that inhibition of the synthesis of NO with
-NMMA does not modify L-FMC, suggesting that NO
as a lesser role in maintaining resting conduit artery tone.
n contrast, the significant blunting of L-FMC observed
fter fluconazole and aspirin administration allows the
ypothesis that cytochrome P450-derived EDHF and/or
yclooxygenase products (such as prostaglandins) are ac-
ively secreted in resting conditions by the endothelium of
onduit arteries (7) and that this production is decreased in
onditions of reduced shear stress. Finally, Spieker et al.
10) reported that inhibition of type A receptors of
ndothelin-1 reduces L-FMC. Therefore, we hypothesize
hat L-FMC might be mediated by a coordinated effect of
asodilator (a P450-derived EDHF and cyclooxygenase
roducts) inhibition and increased endothelin-1 production.
his emphasizes the importance of L-FMC as an adjunct to
MD measurement, as, taken together, these 2 measures
rovide more comprehensive information on the multiple
olecular pathways involved in the control of vascular
omeostasis. Future studies will have to identify the exact
ature of these mediators.
onclusions
n sum, the reproducibility and repeatability of L-FMC is
omparable to that of traditional FMD; L-FMC, as well as
Young After Smoking Coronary Artery Disease Hypertension
29 1 (25–32)* 65 7 (54–70)* 53 11 (35–65)*
2.22 0.4 2.89 0.5† 2.51 0.4†
0.07 0.08‡ 0.01 0.06‡ 0.06 0.06‡
0.10 0.12‡ 0.09 0.08‡ 0.11 0.06‡
24 33 20 11 25 31
5 6 6 4 4 3
179 205 165 84 129 82
67 15 64 10 72 13
g groups in resting blood flow were due to 3 outliers (1 each in the healthy young, the smoking,
roups. *p 0.01 analysis of variance among groups; †p 0.01 compared with younger subjects;d
s amon
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Assessment of Vascular Function May 20, 2008:1953–8MD, is blunted after smoking in patients with CAD and
n hypertensive patients. Because it can be obtained at the
ame time as FMD measurements and it yields information
hat is both complementary and additive to that of FMD,
he introduction of L-FMC provides a simple yet more
omprehensive assessment of vascular function for patho-
hysiological and pharmacologic studies as well as for
linical prevention programs.
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